Skip to content

Clinical trials

Phase 2/3 Glaucoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glaucoma Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20102
20141
20181
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wills Eye3
Alexandria University1
Athens Vision Eye Institute1
Medical University of Vienna1
Nicox Ophthalmics, Inc.1
Prince of Songkla University1
Qlaris Bio, Inc.1
Samsung Medical Center1
University Hospital Dubrava1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glaucoma11
Glaucoma, Open-Angle3
Corneal Edema1
Exfoliation Syndrome1
Glaucoma, Angle-Closure1
Glaucoma, Neovascular1
Macular Degeneration1
Ocular Hypertension1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.